From: Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo
Variable
Contrast
Hazard ratio
95% hazard ratio confidence limits
p value
Median survival (weeks)
Lower
Upper
Treatment
CTR vs. Bor
4.1
1.28
13.11
0.0172
5.75 vs. 7.25